| |
|
|
|
Registro Completo |
|
Biblioteca(s): |
Embrapa Meio Ambiente. |
|
Data corrente: |
16/05/2018 |
|
Data da última atualização: |
28/07/2021 |
|
Tipo da produção científica: |
Boletim de Pesquisa e Desenvolvimento |
|
Autoria: |
FRASCA-SCORVO, C. M. D.; LOSEKANN, M. E.; QUEIROZ, J. F. de; SCORVO Filho, J. D.; TURCO, P. G. N. |
|
Afiliação: |
Célia Maria Dória Frasca-Scorvo, SAA São Paulo; MARCOS ELISEU LOSEKANN, CNPMA; JULIO FERRAZ DE QUEIROZ, CNPMA; João Donato Scorvo Filho, Agência Paulista de Tecnologias dos Agronegócios da SAA São Paulo, Monte Alegre do Sul; Patrícia Helena Nogueira Turco, Agência Paulista de Tecnologias dos Agronegócios da SAA São Paulo, Monte Alegre do Sul. |
|
Título: |
Avaliação da frequência alimentar no desempenho de tilápia em uma represa rural. |
|
Ano de publicação: |
2017 |
|
Fonte/Imprenta: |
Jaguariúna: Embrapa Meio Ambiente, 2017. |
|
Páginas: |
17 p. |
|
Série: |
(Boletim de Pesquisa e Desenvolvimento / Embrapa Meio Ambiente , ISSN 1516-4675 ; 75). |
|
Idioma: |
Português |
|
Thesagro: |
Alimento; Oreochromis Niloticus; Peixe; Tilápia. |
|
Categoria do assunto: |
S Ciências Biológicas |
|
URL: |
https://ainfo.cnptia.embrapa.br/digital/bitstream/item/178689/1/2018BP02.pdf
|
|
Marc: |
LEADER 00712nam a2200217 a 4500
001 2091492
005 2021-07-28
008 2017 bl uuuu u0uu1 u #d
100 1 $aFRASCA-SCORVO, C. M. D.
245 $aAvaliação da frequência alimentar no desempenho de tilápia em uma represa rural.$h[electronic resource]
260 $aJaguariúna: Embrapa Meio Ambiente$c2017
300 $a17 p.
490 $a(Boletim de Pesquisa e Desenvolvimento / Embrapa Meio Ambiente , ISSN 1516-4675 ; 75).
650 $aAlimento
650 $aOreochromis Niloticus
650 $aPeixe
650 $aTilápia
700 1 $aLOSEKANN, M. E.
700 1 $aQUEIROZ, J. F. de
700 1 $aSCORVO Filho, J. D.
700 1 $aTURCO, P. G. N.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Meio Ambiente (CNPMA) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
URL |
Voltar
|
|
|
 | Acesso ao texto completo restrito à biblioteca da Embrapa Gado de Leite. Para informações adicionais entre em contato com cnpgl.biblioteca@embrapa.br. |
Registro Completo
|
Biblioteca(s): |
Embrapa Gado de Leite. |
|
Data corrente: |
14/03/2013 |
|
Data da última atualização: |
09/02/2024 |
|
Tipo da produção científica: |
Artigo em Periódico Indexado |
|
Circulação/Nível: |
A - 2 |
|
Autoria: |
MAZZOCCOLI, L.; CARDOSO, SILVIA H.; AMARANTE, G. W.; SOUZA, M. V. N. DE; DOMINGUES, R.; MACHADO, M. A.; ALMEIDA, M. V. DE; TEIXEIRA, H. C. |
|
Afiliação: |
LUCIANO MAZZOCCOLI, UFJF; SILVIA H. CARDOSO, UFJF; GIOVANNI W. AMARANTE, UFJF; MARCUS V. N. DE SOUZA, UFJF; ROBERT DOMINGUES, CPPSUL; MARCO ANTONIO MACHADO, CNPGL; MAURO V. DE ALMEIDA, UFJF; HENRIQUE C. TEIXEIRA, UFJF. |
|
Título: |
Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10. |
|
Ano de publicação: |
2012 |
|
Fonte/Imprenta: |
Biomedicine & Pharmacotherapy, v. 66, p. 323-329, 2012. |
|
DOI: |
https://doi.org/10.1016/j.biopha.2012.05.001 |
|
Idioma: |
Inglês |
|
Notas: |
Não consta da meta de 2012. |
|
Conteúdo: |
Thalidomide is used to treat a variety of diseases including erythema nodosum leprosum, an inflammatory complication of leprosy. However, this drug has severe teratogenic activity and novel thalidomide analogues might be used to treat diseases without this severe side effect. A series of diamine compounds containing two hydrolyzed phthalimide units were chosen as analogues of thalidomide and evaluated regarding their capacity to regulate the production of molecules involved in inflammatory responses. TNF-α, IL-12 and IL-10 production, and the expression of CD80 and CD86 were investigated in LPS plus IFN-γ-stimulated J774A.1 cells by ELISA and flow cytometry, respectively. The expression of TNF-α and IL-10 mRNA was analyzed by real time RT-PCR. TNF-α, IL-6, IFN-γ, CXCL9 and CXCL10 production by human peripheral blood mononuclear cells (PBMC) were evaluated by flow cytometry. Compounds 3, 6 and 9 greatly inhibited TNF-α and IL-12 production while enhancing IL-10. In addition, CD80 expression was inhibited, but not CD86. The compounds inhibited TNF-α production by PBMC more than thalidomide and also had an inhibitory effect on the production of IL-6, IFN-γ, CXCL9 and CXCL10. Levels of mRNA for TNF-α were reduced after treatment with the compounds, suggesting post- transcriptional effects. The compounds had no effect on cell viability. Our results indicate that the novel diamine compounds 3, 6 and 9 inhibit critical pro-inflammatory cytokines and stimulate IL-10, which make them attractive candidate drugs for the treatment of certain inflammatory conditions and cancer. MenosThalidomide is used to treat a variety of diseases including erythema nodosum leprosum, an inflammatory complication of leprosy. However, this drug has severe teratogenic activity and novel thalidomide analogues might be used to treat diseases without this severe side effect. A series of diamine compounds containing two hydrolyzed phthalimide units were chosen as analogues of thalidomide and evaluated regarding their capacity to regulate the production of molecules involved in inflammatory responses. TNF-α, IL-12 and IL-10 production, and the expression of CD80 and CD86 were investigated in LPS plus IFN-γ-stimulated J774A.1 cells by ELISA and flow cytometry, respectively. The expression of TNF-α and IL-10 mRNA was analyzed by real time RT-PCR. TNF-α, IL-6, IFN-γ, CXCL9 and CXCL10 production by human peripheral blood mononuclear cells (PBMC) were evaluated by flow cytometry. Compounds 3, 6 and 9 greatly inhibited TNF-α and IL-12 production while enhancing IL-10. In addition, CD80 expression was inhibited, but not CD86. The compounds inhibited TNF-α production by PBMC more than thalidomide and also had an inhibitory effect on the production of IL-6, IFN-γ, CXCL9 and CXCL10. Levels of mRNA for TNF-α were reduced after treatment with the compounds, suggesting post- transcriptional effects. The compounds had no effect on cell viability. Our results indicate that the novel diamine compounds 3, 6 and 9 inhibit critical pro-inflammatory cytokines and stimulate IL-10, which make them... Mostrar Tudo |
|
Palavras-Chave: |
IL-10; Resposta inflamatória; Talidomida analógico; TNF-a. |
|
Categoria do assunto: |
H Saúde e Patologia |
|
Marc: |
LEADER 02493naa a2200277 a 4500
001 1953088
005 2024-02-09
008 2012 bl uuuu u00u1 u #d
024 7 $ahttps://doi.org/10.1016/j.biopha.2012.05.001$2DOI
100 1 $aMAZZOCCOLI, L.
245 $aNovel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10.$h[electronic resource]
260 $c2012
500 $aNão consta da meta de 2012.
520 $aThalidomide is used to treat a variety of diseases including erythema nodosum leprosum, an inflammatory complication of leprosy. However, this drug has severe teratogenic activity and novel thalidomide analogues might be used to treat diseases without this severe side effect. A series of diamine compounds containing two hydrolyzed phthalimide units were chosen as analogues of thalidomide and evaluated regarding their capacity to regulate the production of molecules involved in inflammatory responses. TNF-α, IL-12 and IL-10 production, and the expression of CD80 and CD86 were investigated in LPS plus IFN-γ-stimulated J774A.1 cells by ELISA and flow cytometry, respectively. The expression of TNF-α and IL-10 mRNA was analyzed by real time RT-PCR. TNF-α, IL-6, IFN-γ, CXCL9 and CXCL10 production by human peripheral blood mononuclear cells (PBMC) were evaluated by flow cytometry. Compounds 3, 6 and 9 greatly inhibited TNF-α and IL-12 production while enhancing IL-10. In addition, CD80 expression was inhibited, but not CD86. The compounds inhibited TNF-α production by PBMC more than thalidomide and also had an inhibitory effect on the production of IL-6, IFN-γ, CXCL9 and CXCL10. Levels of mRNA for TNF-α were reduced after treatment with the compounds, suggesting post- transcriptional effects. The compounds had no effect on cell viability. Our results indicate that the novel diamine compounds 3, 6 and 9 inhibit critical pro-inflammatory cytokines and stimulate IL-10, which make them attractive candidate drugs for the treatment of certain inflammatory conditions and cancer.
653 $aIL-10
653 $aResposta inflamatória
653 $aTalidomida analógico
653 $aTNF-a
700 1 $aCARDOSO, SILVIA H.
700 1 $aAMARANTE, G. W.
700 1 $aSOUZA, M. V. N. DE
700 1 $aDOMINGUES, R.
700 1 $aMACHADO, M. A.
700 1 $aALMEIDA, M. V. DE
700 1 $aTEIXEIRA, H. C.
773 $tBiomedicine & Pharmacotherapy$gv. 66, p. 323-329, 2012.
Download
Esconder MarcMostrar Marc Completo |
|
Registro original: |
Embrapa Gado de Leite (CNPGL) |
|
|
Biblioteca |
ID |
Origem |
Tipo/Formato |
Classificação |
Cutter |
Registro |
Volume |
Status |
Fechar
|
| Nenhum registro encontrado para a expressão de busca informada. |
|
|
